Cypherpunk Technologies Inc. (CYPH): Cash & Equivalents
$14.04M
As of 2025-12-31
$7.62M
As of 2026-06-30
-40.2%
3-year compound annual growth
-23.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.04M | -70.3% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $47.25M | -33.1% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $70.64M | +7.9% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $65.50M | -43.0% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $114.92M | +120.7% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $52.07M | n/m | 2022-03-11, Balance as of period end |
| 2019-12-31 | $3.89M | -76.1% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $16.28M | -36.7% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $25.74M | n/m | 2019-04-01, Balance as of period end |
| 2016-12-31 | $793.0K | n/a | 2018-02-23, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $14.04M | -70.3% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $17.81M | +206.5% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $1.64M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $19.96M | -18.8% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $37.07M | +213.8% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $35.69M | -59.1% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $28.49M | +65.7% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $22.81M | +11.0% |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | $17.87M | -32.8% |
Compare CYPH, RNAZ, APUS, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗